Dermatology
1 drug is in development for Non-segmental Vitiligo.
- Companies
- 1
- Clinical trials
- 7
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Non-segmental Vitiligo pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| vyn201 | VYNE Therapeutics Inc. (YARW) |
About this indication
Non-segmental Vitiligo context
Dermatology·MeSH: Vitiligo (D014820)
Narrower concept of MeSH descriptor Vitiligo
Frequently asked questions
How many drugs are in development for Non-segmental Vitiligo?
BioSniper tracks 1 drug in development for Non-segmental Vitiligo across 1 company.
How many clinical trials target Non-segmental Vitiligo?
There are 7 clinical trials targeting Non-segmental Vitiligo tracked by BioSniper.